Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amantadine for COVID-19
2021-001177-22Phase 3Completed
- Sponsor
- Copenhagen University Hospital - Amager and Hvidovre
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Amantadine arm with Placebo arm (2 arms). Primary endpoint: Clinical status on day 14. Started Mar 2021; status: completed.
02
Drugs
amantadine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on 2021-001177-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-001177-22.